How big is the measle vaccine market?

Global Measle Vaccine Market Insights and Forecast to 2028

Code: QYRE-Auto-27P9049

Report

January 2022

Pages:72

QYResearch

Description

Table of Content

Tables & Figures

FEATURED COMPANIES

Merck

Biovac

McKesson Medical

Measles vaccine is made by inoculation of attenuated strain of measles virus into chicken embryo cells, culture and harvesting of virus venom, and then freeze-drying. Injection into the lateral deltoid muscle attachment of the upper arm can prevent measles.

Market Analysis and Insights: Global Measle Vaccine Market

Due to the COVID-19 pandemic, the global Measle Vaccine market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period.

Fully considering the economic change by this health crisis, Inactivated Vaccine accounting for % of the Measle Vaccine global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period.

While Hospital segment is altered to an % CAGR throughout this forecast period.

China Measle Vaccine market size is valued at US$ million in 2021, while the US and Europe Measle Vaccine are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period.

As for the Europe Measle Vaccine landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.

The global key manufacturers of Measle Vaccine include Merck, Biovac and McKesson Medical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

Global Measle Vaccine Scope and Segment

Measle Vaccine market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Measle Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

Inactivated Vaccine

Attenuated Vaccine

Segment by Application

Hospital

Scientific Research

Others

BY COMPANY

Merck

Biovac

McKesson Medical

BY REGION

North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Indonesia

Thailand

Malaysia

Philippines

Vietnam

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

U.A.E

FEATURED COMPANIES

Merck

Biovac

McKesson Medical

1 Study Coverage

1.1 Measle Vaccine Product Introduction

1.2 Market by Type

1.2.1 Global Measle Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028

1.2.2 Inactivated Vaccine

1.2.3 Attenuated Vaccine

1.3 Market by Application

1.3.1 Global Measle Vaccine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028

1.3.2 Hospital

1.3.3 Scientific Research

1.3.4 Others

1.4 Study Objectives

1.5 Years Considered

2 Executive Summary

2.1 Global Measle Vaccine Sales Estimates and Forecasts 2017-2028

2.2 Global Measle Vaccine Revenue Estimates and Forecasts 2017-2028

2.3 Global Measle Vaccine Revenue by Region: 2017 VS 2021 VS 2028

2.4 Global Measle Vaccine Sales by Region

2.4.1 Global Measle Vaccine Sales by Region (2017-2022)

2.4.2 Global Sales Measle Vaccine by Region (2023-2028)

2.5 Global Measle Vaccine Revenue by Region

2.5.1 Global Measle Vaccine Revenue by Region (2017-2022)

2.5.2 Global Measle Vaccine Revenue by Region (2023-2028)

2.6 North America

2.7 Europe

2.8 Asia-Pacific

2.9 Latin America

2.10 Middle East & Africa

3 Competition by Manufacturers

3.1 Global Measle Vaccine Sales by Manufacturers

3.1.1 Global Top Measle Vaccine Manufacturers by Sales (2017-2022)

3.1.2 Global Measle Vaccine Sales Market Share by Manufacturers (2017-2022)

3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Measle Vaccine in 2021

3.2 Global Measle Vaccine Revenue by Manufacturers

3.2.1 Global Measle Vaccine Revenue by Manufacturers (2017-2022)

3.2.2 Global Measle Vaccine Revenue Market Share by Manufacturers (2017-2022)

3.2.3 Global Top 10 and Top 5 Companies by Measle Vaccine Revenue in 2021

3.3 Global Measle Vaccine Sales Price by Manufacturers (2017-2022)

3.4 Analysis of Competitive Landscape

3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Measle Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.4.3 Global Measle Vaccine Manufacturers Geographical Distribution

3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

4.1 Global Measle Vaccine Sales by Type

4.1.1 Global Measle Vaccine Historical Sales by Type (2017-2022)

4.1.2 Global Measle Vaccine Forecasted Sales by Type (2023-2028)

4.1.3 Global Measle Vaccine Sales Market Share by Type (2017-2028)

4.2 Global Measle Vaccine Revenue by Type

4.2.1 Global Measle Vaccine Historical Revenue by Type (2017-2022)

4.2.2 Global Measle Vaccine Forecasted Revenue by Type (2023-2028)

4.2.3 Global Measle Vaccine Revenue Market Share by Type (2017-2028)

4.3 Global Measle Vaccine Price by Type

4.3.1 Global Measle Vaccine Price by Type (2017-2022)

4.3.2 Global Measle Vaccine Price Forecast by Type (2023-2028)

5 Market Size by Application

5.1 Global Measle Vaccine Sales by Application

5.1.1 Global Measle Vaccine Historical Sales by Application (2017-2022)

5.1.2 Global Measle Vaccine Forecasted Sales by Application (2023-2028)

5.1.3 Global Measle Vaccine Sales Market Share by Application (2017-2028)

5.2 Global Measle Vaccine Revenue by Application

5.2.1 Global Measle Vaccine Historical Revenue by Application (2017-2022)

5.2.2 Global Measle Vaccine Forecasted Revenue by Application (2023-2028)

5.2.3 Global Measle Vaccine Revenue Market Share by Application (2017-2028)

5.3 Global Measle Vaccine Price by Application

5.3.1 Global Measle Vaccine Price by Application (2017-2022)

5.3.2 Global Measle Vaccine Price Forecast by Application (2023-2028)

6 North America

6.1 North America Measle Vaccine Market Size by Type

6.1.1 North America Measle Vaccine Sales by Type (2017-2028)

6.1.2 North America Measle Vaccine Revenue by Type (2017-2028)

6.2 North America Measle Vaccine Market Size by Application

6.2.1 North America Measle Vaccine Sales by Application (2017-2028)

6.2.2 North America Measle Vaccine Revenue by Application (2017-2028)

6.3 North America Measle Vaccine Market Size by Country

6.3.1 North America Measle Vaccine Sales by Country (2017-2028)

6.3.2 North America Measle Vaccine Revenue by Country (2017-2028)

6.3.3 U.S.

6.3.4 Canada

7 Europe

7.1 Europe Measle Vaccine Market Size by Type

7.1.1 Europe Measle Vaccine Sales by Type (2017-2028)

7.1.2 Europe Measle Vaccine Revenue by Type (2017-2028)

7.2 Europe Measle Vaccine Market Size by Application

7.2.1 Europe Measle Vaccine Sales by Application (2017-2028)

7.2.2 Europe Measle Vaccine Revenue by Application (2017-2028)

7.3 Europe Measle Vaccine Market Size by Country

7.3.1 Europe Measle Vaccine Sales by Country (2017-2028)

7.3.2 Europe Measle Vaccine Revenue by Country (2017-2028)

7.3.3 Germany

7.3.4 France

7.3.5 U.K.

7.3.6 Italy

7.3.7 Russia

8 Asia Pacific

8.1 Asia Pacific Measle Vaccine Market Size by Type

8.1.1 Asia Pacific Measle Vaccine Sales by Type (2017-2028)

8.1.2 Asia Pacific Measle Vaccine Revenue by Type (2017-2028)

8.2 Asia Pacific Measle Vaccine Market Size by Application

8.2.1 Asia Pacific Measle Vaccine Sales by Application (2017-2028)

8.2.2 Asia Pacific Measle Vaccine Revenue by Application (2017-2028)

8.3 Asia Pacific Measle Vaccine Market Size by Region

8.3.1 Asia Pacific Measle Vaccine Sales by Region (2017-2028)

8.3.2 Asia Pacific Measle Vaccine Revenue by Region (2017-2028)

8.3.3 China

8.3.4 Japan

8.3.5 South Korea

8.3.6 India

8.3.7 Australia

8.3.8 Taiwan

8.3.9 Indonesia

8.3.10 Thailand

8.3.11 Malaysia

8.3.12 Philippines

9 Latin America

9.1 Latin America Measle Vaccine Market Size by Type

9.1.1 Latin America Measle Vaccine Sales by Type (2017-2028)

9.1.2 Latin America Measle Vaccine Revenue by Type (2017-2028)

9.2 Latin America Measle Vaccine Market Size by Application

9.2.1 Latin America Measle Vaccine Sales by Application (2017-2028)

9.2.2 Latin America Measle Vaccine Revenue by Application (2017-2028)

9.3 Latin America Measle Vaccine Market Size by Country

9.3.1 Latin America Measle Vaccine Sales by Country (2017-2028)

9.3.2 Latin America Measle Vaccine Revenue by Country (2017-2028)

9.3.3 Mexico

9.3.4 Brazil

9.3.5 Argentina

10 Middle East and Africa

10.1 Middle East and Africa Measle Vaccine Market Size by Type

10.1.1 Middle East and Africa Measle Vaccine Sales by Type (2017-2028)

10.1.2 Middle East and Africa Measle Vaccine Revenue by Type (2017-2028)

10.2 Middle East and Africa Measle Vaccine Market Size by Application

10.2.1 Middle East and Africa Measle Vaccine Sales by Application (2017-2028)

10.2.2 Middle East and Africa Measle Vaccine Revenue by Application (2017-2028)

10.3 Middle East and Africa Measle Vaccine Market Size by Country

10.3.1 Middle East and Africa Measle Vaccine Sales by Country (2017-2028)

10.3.2 Middle East and Africa Measle Vaccine Revenue by Country (2017-2028)

10.3.3 Turkey

10.3.4 Saudi Arabia

11 Company Profiles

11.1 Merck

11.1.1 Merck Corporation Information

11.1.2 Merck Overview

11.1.3 Merck Measle Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)

11.1.4 Merck Measle Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

11.1.5 Merck Recent Developments

11.2 Biovac

11.2.1 Biovac Corporation Information

11.2.2 Biovac Overview

11.2.3 Biovac Measle Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)

11.2.4 Biovac Measle Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

11.2.5 Biovac Recent Developments

11.3 McKesson Medical

11.3.1 McKesson Medical Corporation Information

11.3.2 McKesson Medical Overview

11.3.3 McKesson Medical Measle Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)

11.3.4 McKesson Medical Measle Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

11.3.5 McKesson Medical Recent Developments

12 Industry Chain and Sales Channels Analysis

12.1 Measle Vaccine Industry Chain Analysis

12.2 Measle Vaccine Key Raw Materials

12.2.1 Key Raw Materials

12.2.2 Raw Materials Key Suppliers

12.3 Measle Vaccine Production Mode & Process

12.4 Measle Vaccine Sales and Marketing

12.4.1 Measle Vaccine Sales Channels

12.4.2 Measle Vaccine Distributors

12.5 Measle Vaccine Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

13.1 Measle Vaccine Industry Trends

13.2 Measle Vaccine Market Drivers

13.3 Measle Vaccine Market Challenges

13.4 Measle Vaccine Market Restraints

14 Key Findings in The Global Measle Vaccine Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Author Details

15.3 Disclaimer

FEATURED COMPANIES

Merck

Biovac

McKesson Medical

List of Tables

Table 1. Global Measle Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)

Table 2. Major Manufacturers of Inactivated Vaccine

Table 3. Major Manufacturers of Attenuated Vaccine

Table 4. Global Measle Vaccine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)

Table 5. Global Measle Vaccine Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)

Table 6. Global Measle Vaccine Sales by Region (2017-2022) & (K Units)

Table 7. Global Measle Vaccine Sales Market Share by Region (2017-2022)

Table 8. Global Measle Vaccine Sales by Region (2023-2028) & (K Units)

Table 9. Global Measle Vaccine Sales Market Share by Region (2023-2028)

Table 10. Global Measle Vaccine Revenue by Region (2017-2022) & (US$ Million)

Table 11. Global Measle Vaccine Revenue Market Share by Region (2017-2022)

Table 12. Global Measle Vaccine Revenue by Region (2023-2028) & (US$ Million)

Table 13. Global Measle Vaccine Revenue Market Share by Region (2023-2028)

Table 14. Global Measle Vaccine Sales by Manufacturers (2017-2022) & (K Units)

Table 15. Global Measle Vaccine Sales Share by Manufacturers (2017-2022)

Table 16. Global Measle Vaccine Revenue by Manufacturers (2017-2022) & (US$ Million)

Table 17. Global Measle Vaccine Revenue Share by Manufacturers (2017-2022)

Table 18. Measle Vaccine Price by Manufacturers (2017-2022) &(USD/Unit)

Table 19. Global Measle Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 20. Global Measle Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Measle Vaccine as of 2021)

Table 21. Measle Vaccine Manufacturing Base Distribution and Headquarters

Table 22. Manufacturers Measle Vaccine Product Offered

Table 23. Date of Manufacturers Enter into Measle Vaccine Market

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Measle Vaccine Sales by Type (2017-2022) & (K Units)

Table 26. Global Measle Vaccine Sales by Type (2023-2028) & (K Units)

Table 27. Global Measle Vaccine Sales Share by Type (2017-2022)

Table 28. Global Measle Vaccine Sales Share by Type (2023-2028)

Table 29. Global Measle Vaccine Revenue by Type (2017-2022) & (US$ Million)

Table 30. Global Measle Vaccine Revenue by Type (2023-2028) & (US$ Million)

Table 31. Global Measle Vaccine Revenue Share by Type (2017-2022)

Table 32. Global Measle Vaccine Revenue Share by Type (2023-2028)

Table 33. Measle Vaccine Price by Type (2017-2022) & (USD/Unit)

Table 34. Global Measle Vaccine Price Forecast by Type (2023-2028) & (USD/Unit)

Table 35. Global Measle Vaccine Sales by Application (2017-2022) & (K Units)

Table 36. Global Measle Vaccine Sales by Application (2023-2028) & (K Units)

Table 37. Global Measle Vaccine Sales Share by Application (2017-2022)

Table 38. Global Measle Vaccine Sales Share by Application (2023-2028)

Table 39. Global Measle Vaccine Revenue by Application (2017-2022) & (US$ Million)

Table 40. Global Measle Vaccine Revenue by Application (2023-2028) & (US$ Million)

Table 41. Global Measle Vaccine Revenue Share by Application (2017-2022)

Table 42. Global Measle Vaccine Revenue Share by Application (2023-2028)

Table 43. Measle Vaccine Price by Application (2017-2022) & (USD/Unit)

Table 44. Global Measle Vaccine Price Forecast by Application (2023-2028) & (USD/Unit)

Table 45. North America Measle Vaccine Sales by Type (2017-2022) & (K Units)

Table 46. North America Measle Vaccine Sales by Type (2023-2028) & (K Units)

Table 47. North America Measle Vaccine Revenue by Type (2017-2022) & (US$ Million)

Table 48. North America Measle Vaccine Revenue by Type (2023-2028) & (US$ Million)

Table 49. North America Measle Vaccine Sales by Application (2017-2022) & (K Units)

Table 50. North America Measle Vaccine Sales by Application (2023-2028) & (K Units)

Table 51. North America Measle Vaccine Revenue by Application (2017-2022) & (US$ Million)

Table 52. North America Measle Vaccine Revenue by Application (2023-2028) & (US$ Million)

Table 53. North America Measle Vaccine Sales by Country (2017-2022) & (K Units)

Table 54. North America Measle Vaccine Sales by Country (2023-2028) & (K Units)

Table 55. North America Measle Vaccine Revenue by Country (2017-2022) & (US$ Million)

Table 56. North America Measle Vaccine Revenue by Country (2023-2028) & (US$ Million)

Table 57. Europe Measle Vaccine Sales by Type (2017-2022) & (K Units)

Table 58. Europe Measle Vaccine Sales by Type (2023-2028) & (K Units)

Table 59. Europe Measle Vaccine Revenue by Type (2017-2022) & (US$ Million)

Table 60. Europe Measle Vaccine Revenue by Type (2023-2028) & (US$ Million)

Table 61. Europe Measle Vaccine Sales by Application (2017-2022) & (K Units)

Table 62. Europe Measle Vaccine Sales by Application (2023-2028) & (K Units)

Table 63. Europe Measle Vaccine Revenue by Application (2017-2022) & (US$ Million)

Table 64. Europe Measle Vaccine Revenue by Application (2023-2028) & (US$ Million)

Table 65. Europe Measle Vaccine Sales by Country (2017-2022) & (K Units)

Table 66. Europe Measle Vaccine Sales by Country (2023-2028) & (K Units)

Table 67. Europe Measle Vaccine Revenue by Country (2017-2022) & (US$ Million)

Table 68. Europe Measle Vaccine Revenue by Country (2023-2028) & (US$ Million)

Table 69. Asia Pacific Measle Vaccine Sales by Type (2017-2022) & (K Units)

Table 70. Asia Pacific Measle Vaccine Sales by Type (2023-2028) & (K Units)

Table 71. Asia Pacific Measle Vaccine Revenue by Type (2017-2022) & (US$ Million)

Table 72. Asia Pacific Measle Vaccine Revenue by Type (2023-2028) & (US$ Million)

Table 73. Asia Pacific Measle Vaccine Sales by Application (2017-2022) & (K Units)

Table 74. Asia Pacific Measle Vaccine Sales by Application (2023-2028) & (K Units)

Table 75. Asia Pacific Measle Vaccine Revenue by Application (2017-2022) & (US$ Million)

Table 76. Asia Pacific Measle Vaccine Revenue by Application (2023-2028) & (US$ Million)

Table 77. Asia Pacific Measle Vaccine Sales by Region (2017-2022) & (K Units)

Table 78. Asia Pacific Measle Vaccine Sales by Region (2023-2028) & (K Units)

Table 79. Asia Pacific Measle Vaccine Revenue by Region (2017-2022) & (US$ Million)

Table 80. Asia Pacific Measle Vaccine Revenue by Region (2023-2028) & (US$ Million)

Table 81. Latin America Measle Vaccine Sales by Type (2017-2022) & (K Units)

Table 82. Latin America Measle Vaccine Sales by Type (2023-2028) & (K Units)

Table 83. Latin America Measle Vaccine Revenue by Type (2017-2022) & (US$ Million)

Table 84. Latin America Measle Vaccine Revenue by Type (2023-2028) & (US$ Million)

Table 85. Latin America Measle Vaccine Sales by Application (2017-2022) & (K Units)

Table 86. Latin America Measle Vaccine Sales by Application (2023-2028) & (K Units)

Table 87. Latin America Measle Vaccine Revenue by Application (2017-2022) & (US$ Million)

Table 88. Latin America Measle Vaccine Revenue by Application (2023-2028) & (US$ Million)

Table 89. Latin America Measle Vaccine Sales by Country (2017-2022) & (K Units)

Table 90. Latin America Measle Vaccine Sales by Country (2023-2028) & (K Units)

Table 91. Latin America Measle Vaccine Revenue by Country (2017-2022) & (US$ Million)

Table 92. Latin America Measle Vaccine Revenue by Country (2023-2028) & (US$ Million)

Table 93. Middle East and Africa Measle Vaccine Sales by Type (2017-2022) & (K Units)

Table 94. Middle East and Africa Measle Vaccine Sales by Type (2023-2028) & (K Units)

Table 95. Middle East and Africa Measle Vaccine Revenue by Type (2017-2022) & (US$ Million)

Table 96. Middle East and Africa Measle Vaccine Revenue by Type (2023-2028) & (US$ Million)

Table 97. Middle East and Africa Measle Vaccine Sales by Application (2017-2022) & (K Units)

Table 98. Middle East and Africa Measle Vaccine Sales by Application (2023-2028) & (K Units)

Table 99. Middle East and Africa Measle Vaccine Revenue by Application (2017-2022) & (US$ Million)

Table 100. Middle East and Africa Measle Vaccine Revenue by Application (2023-2028) & (US$ Million)

Table 101. Middle East and Africa Measle Vaccine Sales by Country (2017-2022) & (K Units)

Table 102. Middle East and Africa Measle Vaccine Sales by Country (2023-2028) & (K Units)

Table 103. Middle East and Africa Measle Vaccine Revenue by Country (2017-2022) & (US$ Million)

Table 104. Middle East and Africa Measle Vaccine Revenue by Country (2023-2028) & (US$ Million)

Table 105. Merck Corporation Information

Table 106. Merck Description and Major Businesses

Table 107. Merck Measle Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)

Table 108. Merck Measle Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

Table 109. Merck Recent Developments

Table 110. Biovac Corporation Information

Table 111. Biovac Description and Major Businesses

Table 112. Biovac Measle Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)

Table 113. Biovac Measle Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

Table 114. Biovac Recent Developments

Table 115. McKesson Medical Corporation Information

Table 116. McKesson Medical Description and Major Businesses

Table 117. McKesson Medical Measle Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)

Table 118. McKesson Medical Measle Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

Table 119. McKesson Medical Recent Developments

Table 120. Key Raw Materials Lists

Table 121. Raw Materials Key Suppliers Lists

Table 122. Measle Vaccine Distributors List

Table 123. Measle Vaccine Customers List

Table 124. Measle Vaccine Market Trends

Table 125. Measle Vaccine Market Drivers

Table 126. Measle Vaccine Market Challenges

Table 127. Measle Vaccine Market Restraints

Table 128. Research Programs/Design for This Report

Table 129. Key Data Information from Secondary Sources

Table 130. Key Data Information from Primary Sources

List of Figures

Figure 1. Measle Vaccine Product Picture

Figure 3. Global Measle Vaccine Market Share by Type in 2021 & 2028

Figure 3. Inactivated Vaccine Product Picture

Figure 4. Attenuated Vaccine Product Picture

Figure 5. Global Measle Vaccine Market Share by Application in 2021 & 2028

Figure 6. Hospital

Figure 7. Scientific Research

Figure 8. Others

Figure 9. Measle Vaccine Report Years Considered

Figure 10. Global Measle Vaccine Sales 2017-2028 (K Units)

Figure 11. Global Measle Vaccine Revenue, (US$ Million), 2017 VS 2021 VS 2028

Figure 12. Global Measle Vaccine Revenue 2017-2028 (US$ Million)

Figure 13. Global Measle Vaccine Revenue Market Share by Region in Percentage: 2021 Versus 2028

Figure 14. Global Measle Vaccine Sales Market Share by Region (2017-2022)

Figure 15. Global Measle Vaccine Sales Market Share by Region (2023-2028)

Figure 16. North America Measle Vaccine Sales YoY (2017-2028) & (K Units)

Figure 17. North America Measle Vaccine Revenue YoY (2017-2028) & (US$ Million)

Figure 18. Europe Measle Vaccine Sales YoY (2017-2028) & (K Units)

Figure 19. Europe Measle Vaccine Revenue YoY (2017-2028) & (US$ Million)

Figure 20. Asia-Pacific Measle Vaccine Sales YoY (2017-2028) & (K Units)

Figure 21. Asia-Pacific Measle Vaccine Revenue YoY (2017-2028) & (US$ Million)

Figure 22. Latin America Measle Vaccine Sales YoY (2017-2028) & (K Units)

Figure 23. Latin America Measle Vaccine Revenue YoY (2017-2028) & (US$ Million)

Figure 24. Middle East & Africa Measle Vaccine Sales YoY (2017-2028) & (K Units)

Figure 25. Middle East & Africa Measle Vaccine Revenue YoY (2017-2028) & (US$ Million)

Figure 26. The Measle Vaccine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021

Figure 27. The Top 5 and 10 Largest Manufacturers of Measle Vaccine in the World: Market Share by Measle Vaccine Revenue in 2021

Figure 28. Global Measle Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021

Figure 29. Global Measle Vaccine Sales Market Share by Type (2017-2028)

Figure 30. Global Measle Vaccine Revenue Market Share by Type (2017-2028)

Figure 31. Global Measle Vaccine Sales Market Share by Application (2017-2028)

Figure 32. Global Measle Vaccine Revenue Market Share by Application (2017-2028)

Figure 33. North America Measle Vaccine Sales Market Share by Type (2017-2028)

Figure 34. North America Measle Vaccine Revenue Market Share by Type (2017-2028)

Figure 35. North America Measle Vaccine Sales Market Share by Application (2017-2028)

Figure 36. North America Measle Vaccine Revenue Market Share by Application (2017-2028)

Figure 37. North America Measle Vaccine Sales Share by Country (2017-2028)

Figure 38. North America Measle Vaccine Revenue Share by Country (2017-2028)

Figure 39. U.S. Measle Vaccine Revenue (2017-2028) & (US$ Million)

Figure 40. Canada Measle Vaccine Revenue (2017-2028) & (US$ Million)

Figure 41. Europe Measle Vaccine Sales Market Share by Type (2017-2028)

Figure 42. Europe Measle Vaccine Revenue Market Share by Type (2017-2028)

Figure 43. Europe Measle Vaccine Sales Market Share by Application (2017-2028)

Figure 44. Europe Measle Vaccine Revenue Market Share by Application (2017-2028)

Figure 45. Europe Measle Vaccine Sales Share by Country (2017-2028)

Figure 46. Europe Measle Vaccine Revenue Share by Country (2017-2028)

Figure 47. Germany Measle Vaccine Revenue (2017-2028) & (US$ Million)

Figure 48. France Measle Vaccine Revenue (2017-2028) & (US$ Million)

Figure 49. U.K. Measle Vaccine Revenue (2017-2028) & (US$ Million)

Figure 50. Italy Measle Vaccine Revenue (2017-2028) & (US$ Million)

Figure 51. Russia Measle Vaccine Revenue (2017-2028) & (US$ Million)

Figure 52. Asia Pacific Measle Vaccine Sales Market Share by Type (2017-2028)

Figure 53. Asia Pacific Measle Vaccine Revenue Market Share by Type (2017-2028)

Figure 54. Asia Pacific Measle Vaccine Sales Market Share by Application (2017-2028)

Figure 55. Asia Pacific Measle Vaccine Revenue Market Share by Application (2017-2028)

Figure 56. Asia Pacific Measle Vaccine Sales Share by Region (2017-2028)

Figure 57. Asia Pacific Measle Vaccine Revenue Share by Region (2017-2028)

Figure 58. China Measle Vaccine Revenue (2017-2028) & (US$ Million)

Figure 59. Japan Measle Vaccine Revenue (2017-2028) & (US$ Million)

Figure 60. South Korea Measle Vaccine Revenue (2017-2028) & (US$ Million)

Figure 61. India Measle Vaccine Revenue (2017-2028) & (US$ Million)

Figure 62. Australia Measle Vaccine Revenue (2017-2028) & (US$ Million)

Figure 63. Taiwan Measle Vaccine Revenue (2017-2028) & (US$ Million)

Figure 64. Indonesia Measle Vaccine Revenue (2017-2028) & (US$ Million)

Figure 65. Thailand Measle Vaccine Revenue (2017-2028) & (US$ Million)

Figure 66. Malaysia Measle Vaccine Revenue (2017-2028) & (US$ Million)

Figure 67. Philippines Measle Vaccine Revenue (2017-2028) & (US$ Million)

Figure 68. Latin America Measle Vaccine Sales Market Share by Type (2017-2028)

Figure 69. Latin America Measle Vaccine Revenue Market Share by Type (2017-2028)

Figure 70. Latin America Measle Vaccine Sales Market Share by Application (2017-2028)

Figure 71. Latin America Measle Vaccine Revenue Market Share by Application (2017-2028)

Figure 72. Latin America Measle Vaccine Sales Share by Country (2017-2028)

Figure 73. Latin America Measle Vaccine Revenue Share by Country (2017-2028)

Figure 74. Mexico Measle Vaccine Revenue (2017-2028) & (US$ Million)

Figure 75. Brazil Measle Vaccine Revenue (2017-2028) & (US$ Million)

Figure 76. Argentina Measle Vaccine Revenue (2017-2028) & (US$ Million)

Figure 77. Middle East and Africa Measle Vaccine Sales Market Share by Type (2017-2028)

Figure 78. Middle East and Africa Measle Vaccine Revenue Market Share by Type (2017-2028)

Figure 79. Middle East and Africa Measle Vaccine Sales Market Share by Application (2017-2028)

Figure 80. Middle East and Africa Measle Vaccine Revenue Market Share by Application (2017-2028)

Figure 81. Middle East and Africa Measle Vaccine Sales Share by Country (2017-2028)

Figure 82. Middle East and Africa Measle Vaccine Revenue Share by Country (2017-2028)

Figure 83. Turkey Measle Vaccine Revenue (2017-2028) & (US$ Million)

Figure 84. Saudi Arabia Measle Vaccine Revenue (2017-2028) & (US$ Million)

Figure 85. U.A.E Measle Vaccine Revenue (2017-2028) & (US$ Million)

Figure 86. Measle Vaccine Value Chain

Figure 87. Measle Vaccine Production Process

Figure 88. Channels of Distribution

Figure 89. Distributors Profiles

Figure 90. Bottom-up and Top-down Approaches for This Report

Figure 91. Data Triangulation

Figure 92. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (10% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Measle Vaccine Market Insights and Forecast to 2028

Published Date: January 2022

Report Code: QYRE-Auto-27P9049

Global Measle Vaccine Market Insights and Forecast to 2028

FEATURED COMPANIES

Segment by Type

Segment by Application

BY COMPANY

BY REGION

FEATURED COMPANIES

FEATURED COMPANIES

HAVE A QUERY?

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-26K6048

Mon Apr 15 00:00:00 UTC 2024

120 Pages

Type: Report

Code: QYRE-Auto-20L6129

Mon Apr 15 00:00:00 UTC 2024

120 Pages

Type: Report

Code: QYRE-Auto-4F6384

Mon Apr 15 00:00:00 UTC 2024

120 Pages

Type: Report

Code: QYRE-Auto-16N6009

Mon Apr 15 00:00:00 UTC 2024

Support Contacts

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

POLICIES

THE COMPANY

CUSTOMER SUPPORT

OUR PRODUCTS

POLICES

Copyright © 2018 Valuates.com. All Rights Reserved.

Sitemap - Privacy Policy - Terms & Conditions